منابع مشابه
Cure of hepatitis C.
Since the discovery of the hepatitis C virus in 1989, many epidemiological data have been acquired, especially in Europe. Treatments have showed substantial improvement over the past 25 years and have taken a great leap forward with the development of the direct antiviral agents (DAAs). However, the burden of hepatitis C remains important in Europe with more than 5 million individuals living wi...
متن کامل“Sell an Ox” - The Price of Cure for Hepatitis C in Two Countries
Chronic hepatitis C virus (HCV) infection, associated with severe liver disease and cancer, affects 70 million people worldwide. New treatments with direct-acting-antivirals offer cure for about 95% of affected individuals; however, treatment costs may be prohibitive in both the poorest and richest nations. Opting for cure may require sacrificing essential household ass...
متن کاملHepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?
The recent advances in hepatitis C virus (HCV) therapeutics have brought combinations of direct acting antiviral medications that offer interferon-free, well-tolerated regimens with sustained virologic response rates greater than 90% in clinical trials for many patient groups. The successes have prompted discussions regarding cure for all patients. These regimens have already demonstrated the a...
متن کاملSuccesses and Challenges on the Road to Cure Hepatitis C
Hepatitis C virus (HCV) represents a significant health burden worldwide, with an estimated 185 million people chronically infected [1]. A leading cause of liver transplantation, HCV infection can result in severe liver disease including cirrhosis and hepatocellular carcinoma [2]. Cure of HCV infection results in substantial decreases in such liver-related morbidity and mortality [3]. Prior the...
متن کاملHepatitis C cure with antiviral therapy--benefits beyond the liver.
Liver disease is the major complication of chronic HCV infection. However, extrahepatic complications are common (50-75%), including mixed cryoglobulinaemia and B-cell lymphomas. Given that chronic hepatitis C has become curable using expensive oral direct-acting antivirals (DAAs), it seems worth revisiting the whole spectrum and burden of disease in HCV carriers.Herein, we update the most clin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Médica Portuguesa
سال: 2015
ISSN: 1646-0758,0870-399X
DOI: 10.20344/amp.6148